Skip to content
Screener

Stock-Based Comp at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$458M+11.7%
Stryker logo
StrykerSYK
$87M+3.6%
Globus Medical logo
Globus MedicalGMED
$13.38M-1.7%
Alphatec Holdings logo
Alphatec HoldingsATEC
$23.66M+6.0%
Enovis logo
EnovisENOV
$8.97M+3.5%
OrthoPediatrics logo
OrthoPediatricsKIDS
$4.19M-20.2%

Other financials

Income statement

See full
Revenue$210.9M+3.8%
Gross profit$149.7M+7.3%
Operating income-$8.1M+49.2%
Net income-$15.8M-12.2%
EPS (diluted)-$0.39-8.3%

Balance sheet

See full
Cash & equivalents$103.8M+58.2%
Total debt$237.7M+33.3%
Total equity$429.2M-6.4%
Total assets$873.0M+4.3%

Cash flow

See full
Operating cash flow-$6.2M-153%
CapEx$12.6M+77.9%
Free cash flow-$18.9M

Valuation

See full
Market cap$418.73M-18.1%
Enterprise value$552.6M-11.4%
P/S0.5×-0.1×

Profitability

See full
Gross margin71.3%+3.9pp
Operating margin-4.8%-1.8pp
Net margin-7.4%-2.5pp
FCF margin-9.7%-1.8pp

Returns & leverage

See full
Return on equity-13.9%-4.2pp
Debt / equity0.6×+0.2×
Current ratio2.8×+0.2×

Where this comes from

Reported directly by Orthofix Medical Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The source filing: Orthofix Medical Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 7:06 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-333822
(Unaudited, U.S. Dollars, in thousands)Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Amortization of operating lease assets, debt costs, and other assets2,1462,377
Provision for expected credit losses3,5911,837
Deferred income taxes43212
Share-based compensation expense14,26814,293
Loss on disposal of fixed assets404581
Change in valuation of investment securities(16)(31)
Change in fair value of contingent consideration1,618(1,373)
Other890(1,188)

Item 1. Financial Statements

FAQ

What is Orthofix Medical Inc.'s stock-based comp?
Orthofix Medical Inc. (OFIX) reported stock-based comp of $7.74M in Q2 2026.
How has Orthofix Medical Inc.'s stock-based comp changed year-over-year?
Orthofix Medical Inc.'s stock-based comp decreased by 1.1% year-over-year, from $7.82M to $7.74M.
What is the long-term trend for Orthofix Medical Inc.'s stock-based comp?
Over 4 years (2021 to 2025), Orthofix Medical Inc.'s stock-based comp has grown at a 16.8% compound annual growth rate (CAGR), from $15.43M to $28.69M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Ask your AI about Orthofix Medical Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude